REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Zoetis Ceska Republika, S.R.O. (Czech Republic)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Lessors of Other Real Estate Property | Professional, Scientific, and Technical Services | Custom Computer Programming Services
Full name: Zoetis Ceska Republika, S.R.O. Profile Updated: February 10, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Zoetis Ceska Republika, S.R.O. is the Czech subsidiary of Zoetis, a global animal health company that researches, develops, manufactures and markets veterinary medicines, vaccines and related solutions. The company serves veterinarians, livestock producers and pet owners with products for companion animals and farm animals, supported by a diagnostic portfolio and customer service activities.

Headquarters
namesti 14. rijna 642/17
Prague; The City of Prague; Postal Code: 15000

Contact Details: Purchase the Zoetis Ceska Republika, S.R.O. report to view the information.

Website: https://www2.zoetis.cz/

Basic Information
Total Employees:
Purchase the Zoetis Ceska Republika, S.R.O. report to view the information.
Registered Capital:
Purchase the Zoetis Ceska Republika, S.R.O. report to view the information.
Financial Auditors:
Purchase the Zoetis Ceska Republika, S.R.O. report to view the information.
Incorporation Date:
August 22, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
99.99%
Purchase this report to view the information.
0.01%
Company Performance
Financial values in the chart are available after Zoetis Ceska Republika, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
11.59%▲
Total operating revenue
11.59%▲
Operating Profit/Loss (EBIT)
-31.98%▼
EBITDA
-13.16%▼
Net Profit/Loss for the Period
-25.93%▼
Total Assets
1.11%▲
Total Equity
7.59%▲
Operating Profit Margin (ROS)
-1.49%▼
Net Profit Margin
-2.2%▼
Return on Equity (ROE)
-3.19%▼
Quick Ratio
0.42%▲

Similar companies

Phoenix Lekarensky Velkoobchod, S.R.O.
 
Alliance Healthcare S.R.O.
Zentiva, K.S.
 
Pharmos, A.S.
Solvent Cr S.R.O.
 
Glenmark Pharmaceuticals S.R.O.
Omega Pharma A.S.
 
Fl Service, S.R.O.
3Ech Pharma S.R.O.
 
Amway Ceska Republika A Slovensko, S.R.O.
Tzmo Czech Republic S.R.O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo